Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19

NCT04806815 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2021-06-30

No results posted yet for this study

Summary

The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health. The aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.

Conditions

  • Menstrual Problem
  • Covid19
  • Fatigue

Interventions

OTHER

A survey of 60 questions was created through the internet-based 'Google Forms surveys' site.

The following tests will be used together with the survey; * Menstrual Symptom Questionnaire * Fatigue Severity Scale * Short Form Of Coronavirus Anxiety Scale

Sponsors & Collaborators

  • Biruni University

    lead OTHER

Principal Investigators

  • Buket Akinci · Biruni University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-18
Primary Completion
2021-05-30
Completion
2021-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04806815 on ClinicalTrials.gov